Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 2.18%1.06B | 1.80%669.18M | 12.83%317.74M | -16.29%1.43B | -16.53%1.03B | -10.72%657.37M | 6.32%281.62M | 2.70%1.71B | 5.52%1.24B | 3.53%736.27M |
| Operating revenue | 2.18%1.06B | 1.80%669.18M | 12.83%317.74M | -16.29%1.43B | -16.53%1.03B | -10.72%657.37M | 6.32%281.62M | 2.70%1.71B | 5.52%1.24B | 3.53%736.27M |
| Other operating revenue | ---- | 10.03%10.79M | ---- | -16.34%20.49M | ---- | -8.40%9.81M | ---- | 145.95%24.49M | ---- | 280.03%10.71M |
| Total operating cost | -6.48%905.84M | -7.71%580.49M | -3.72%274.77M | -11.48%1.32B | -10.17%968.59M | -7.73%628.98M | 3.19%285.38M | -0.85%1.49B | 0.18%1.08B | -0.08%681.63M |
| Operating cost | 2.30%563.67M | 0.69%357.29M | 9.03%171.76M | -16.38%768.95M | -18.00%551.01M | -13.90%354.83M | -0.49%157.53M | -0.39%919.61M | 2.77%671.95M | 1.72%412.11M |
| Operating tax surcharges | -2.73%12.92M | -5.26%7.95M | -8.25%3.36M | 0.63%23.28M | -22.21%13.28M | -21.40%8.39M | -7.73%3.67M | 25.33%23.13M | 33.03%17.07M | 38.31%10.67M |
| Operating expense | -17.39%219.97M | -16.73%144.58M | -18.48%65.07M | -4.65%354.71M | 0.57%266.28M | -1.61%173.63M | 1.61%79.82M | -3.64%372M | -6.59%264.78M | -4.51%176.48M |
| Administration expense | -12.23%70.77M | -12.19%46.22M | -11.65%23.36M | 6.11%103.81M | 11.30%80.63M | 1.12%52.64M | 4.04%26.44M | -10.78%97.83M | -7.81%72.44M | -7.18%52.05M |
| Financial expense | -17.69%7.53M | -2.42%5.07M | 24.40%2.67M | 9.20%13.23M | -15.53%9.15M | -30.26%5.19M | -45.77%2.15M | 31.56%12.11M | 133.53%10.83M | 100.51%7.44M |
| -Interest expense (Financial expense) | -33.73%7.5M | -28.06%5.54M | -14.74%3.42M | -10.25%15.78M | -4.04%11.32M | -0.78%7.7M | -5.95%4.02M | 97.59%17.58M | 126.54%11.79M | 92.86%7.76M |
| -Interest Income (Financial expense) | 47.92%-2.27M | 47.71%-1.92M | 53.07%-1.07M | 31.73%-5.01M | -22.63%-4.36M | -72.10%-3.67M | -191.67%-2.28M | -205.11%-7.34M | 31.56%-3.56M | 37.46%-2.13M |
| Research and development | -35.77%30.98M | -43.47%19.39M | -45.87%8.54M | -16.09%52.65M | 17.08%48.24M | 49.94%34.3M | 148.58%15.77M | 17.06%62.75M | -4.24%41.2M | -7.51%22.87M |
| Credit Impairment Loss | -194.25%-8.49M | -93.64%397.81K | -56.35%2.01M | 109.01%7.81M | 11,636.72%9.01M | 454.61%6.26M | 91.02%4.6M | -360.30%-86.69M | -102.39%-78.08K | -62.92%1.13M |
| Asset Impairment Loss | 4.63%-3.41M | 2.76%-3.7M | 104.03%94.68K | -46.97%-13.35M | -1,071.74%-3.57M | -369.86%-3.8M | -597.16%-2.35M | -70.43%-9.08M | 93.14%-304.91K | -16,037.94%-809.74K |
| Other net revenue | -55.09%19.22M | -30.94%23.42M | -75.15%6.35M | 175.34%37.75M | 45.35%42.78M | 70.71%33.92M | 26.68%25.57M | -936.23%-50.11M | 51.85%29.43M | -4.63%19.87M |
| Fair value change income | -75.46%9.18K | ---- | ---- | -50.57%37.42K | -50.57%37.42K | -62.68%14.75K | -62.68%14.75K | -72.39%75.7K | -72.39%75.7K | 107.21%39.52K |
| Invest income | -15.87%5.94M | -0.80%4.2M | 54.90%2.48M | 43.38%9.83M | 51.44%7.06M | 168.61%4.23M | 54.52%1.6M | 88.37%6.85M | 523.12%4.66M | 158.39%1.57M |
| Asset deal income | -338.29%-883.7K | -544.18%-894.14K | -458.79%-461.94K | -111.28%-107.48K | -51.08%370.85K | -68.05%201.3K | -112.36%-82.67K | 404.22%953.07K | 324.99%758.11K | 173.39%630.14K |
| Other revenue | -12.83%26.04M | -13.31%23.43M | -89.77%2.23M | -11.25%33.53M | 22.85%29.88M | 56.14%27.02M | 33.09%21.79M | 42.29%37.78M | 11.89%24.32M | -1.08%17.31M |
| Operating profit | 57.72%168.46M | 79.91%112.11M | 126.15%49.32M | -11.62%153.58M | -43.28%106.81M | -16.37%62.31M | 156.58%21.81M | 1.00%173.77M | 63.11%188.3M | 49.50%74.51M |
| Add:Non operating Income | -82.89%253.28K | 67.47%245.07K | 52.66%220.53K | 241.85%3.32M | 170.60%1.48M | -72.48%146.34K | 256.67%144.46K | -32.11%970.16K | 65.00%546.97K | 94.53%531.69K |
| Less:Non operating expense | 90.33%3.17M | 219.09%2.5M | 183.71%162.12K | -60.30%2.45M | 111.94%1.67M | 27.72%782.7K | -72.55%57.14K | 682.30%6.18M | 8.54%785.78K | 65.48%612.83K |
| Total profit | 55.26%165.54M | 78.11%109.86M | 125.52%49.38M | -8.37%154.45M | -43.30%106.62M | -17.13%61.68M | 162.79%21.9M | -2.39%168.56M | 63.46%188.06M | 49.63%74.43M |
| Less:Income tax cost | 6.85%27.86M | 8.02%17.55M | 217.54%9.23M | 178.90%32.98M | -23.89%26.07M | 11.53%16.24M | 72.36%2.91M | -64.56%11.83M | 61.64%34.25M | 55.52%14.57M |
| Net profit | 70.92%137.68M | 103.18%92.31M | 111.42%40.15M | -22.50%121.47M | -47.63%80.55M | -24.10%45.43M | 185.75%18.99M | 12.50%156.74M | 63.87%153.81M | 48.26%59.86M |
| Net profit from continuing operation | 70.92%137.68M | 103.18%92.31M | 111.42%40.15M | -22.50%121.47M | -47.63%80.55M | -24.10%45.43M | 185.75%18.99M | 12.50%156.74M | 63.87%153.81M | 48.26%59.86M |
| Net profit of parent company owners | 70.92%137.68M | 103.18%92.31M | 111.42%40.15M | -22.50%121.47M | -47.63%80.55M | -24.10%45.43M | 185.75%18.99M | 12.50%156.74M | 63.87%153.81M | 48.26%59.86M |
| Earning per share | ||||||||||
| Basic earning per share | 73.32%0.4314 | 110.33%0.2892 | 114.31%0.1258 | -22.45%0.38 | -48.94%0.2489 | -27.52%0.1375 | 178.20%0.0587 | 11.36%0.49 | 67.30%0.4875 | 51.28%0.1897 |
| Diluted earning per share | 73.32%0.4314 | 110.33%0.2892 | 114.31%0.1258 | -22.45%0.38 | -48.94%0.2489 | -27.52%0.1375 | 178.20%0.0587 | 11.36%0.49 | 67.30%0.4875 | 51.28%0.1897 |
| Other composite income | ||||||||||
| Total composite income | 70.92%137.68M | 103.18%92.31M | 111.42%40.15M | -22.50%121.47M | -47.63%80.55M | -24.10%45.43M | 185.75%18.99M | 12.50%156.74M | 63.87%153.81M | 48.26%59.86M |
| Total composite income of parent company owners | 70.92%137.68M | 103.18%92.31M | 111.42%40.15M | -22.50%121.47M | -47.63%80.55M | -24.10%45.43M | 185.75%18.99M | 12.50%156.74M | 63.87%153.81M | 48.26%59.86M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianzhi International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.